乡村医院在指南推荐的缺血性卒中溶栓、二级预防及结局方面的表现
这项回顾性队列研究纳入2017至2019年Get With The Guidelines-Stroke医院收治的692 839例急性缺血性卒中患者。乡村卒中中心溶栓率低于城市卒中中心(31.7% vs 43.5%;aOR 0.72),但高于乡村非卒中中心(22.1%;aOR 1.26)。乡村卒中中心二级预防与城市卒中中心相当,院内死亡率无显著差异。
要点
- 乡村卒中中心4.5小时内溶栓率低于城市卒中中心(31.7% vs 43.5%;aOR 0.72)。
- 乡村卒中中心 door-to-needle ≤45分钟比例低于城市卒中中心(33% vs 44.7%;aOR 0.86)。
- 乡村卒中中心二级预防指标与城市卒中中心相当,但优于乡村非卒中中心。
核心结论
- 乡村医院溶栓利用率低于城市医院且治疗速度更慢。
- 乡村卒中中心二级预防治疗与城市卒中中心相当,并优于乡村非卒中中心。
- 这些结果揭示了乡村健康公平干预的重要机会和具体目标。
研究设计与样本
- 回顾性队列研究,纳入2017至2019年Get With The Guidelines-Stroke医院收治的年龄≥18岁急性缺血性卒中患者。
- 共1 127 607例患者入院,其中692 839例符合纳入标准。
- 采用多变量混合效应逻辑回归比较溶栓率、治疗速度、二级预防指标和结局,并校正患者和医院特征及卒中严重程度。
主要发现
- 4.5小时内就诊患者中,乡村卒中中心溶栓率31.7% vs 城市卒中中心43.5%(aOR 0.72,95%CI 0.68-0.76),但超过乡村非卒中中心22.1%(aOR 1.26,95%CI 1.15-1.37)。
- 乡村卒中中心door-to-needle≤45分钟比例33% vs 城市卒中中心44.7%(aOR 0.86,95%CI 0.76-0.96),但高于乡村非卒中中心(aOR 1.24,95%CI 1.04-1.49)。
- 二级预防指标:乡村卒中中心与城市卒中中心相当,但优于乡村非卒中中心,入院48小时内抗血栓、出院抗血栓、房颤/房扑抗凝、他汀治疗和戒烟aOR分别为1.66、1.94、2.44、1.5和1.72。
- 院内死亡率乡村与城市卒中中心相似(aOR 1.11,95%CI 0.99-1.24),与乡村非卒中中心也相似(aOR 1.00,95%CI 0.84-1.18)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Existing data suggested a rural-urban disparity in thrombolytic utilization for ischemic stroke. Here, we examined the use of guideline-recommended stroke care and outcomes in rural hospitals to identify targets for improvement. METHODS: This retrospective cohort study included patients (aged ≥18 years) treated for acute ischemic stroke at Get With The Guidelines-Stroke hospitals from 2017 to 2019. Multivariable mixed-effect logistic regression was used to compare thrombolysis rates, speed of treatment, secondary stroke prevention metrics, and outcomes after adjusting for patient- and hospital-level characteristics and stroke severity. RESULTS: Among the 1 127 607 patients admitted to Get With The Guidelines-Stroke hospitals in 2017 to 2019, 692 839 patients met the inclusion criteria. Patients who presented within 4.5 hours were less likely to receive thrombolysis in rural stroke centers compared with urban stroke centers (31.7% versus 43.5%; adjusted odds ratio [aOR], 0.72 [95% CI, 0.68-0.76]) but exceeded rural nonstroke centers (22.1%; aOR, 1.26 [95% CI, 1.15-1.37]). Rural stroke centers were less likely than urban stroke centers to achieve door-to-needle times of ≤45 minutes (33% versus 44.7%; aOR, 0.86 [95% CI, 0.76-0.96]) but more likely than rural nonstroke centers (aOR, 1.24 [95% CI, 1.04-1.49]). For secondary stroke prevention metrics, rural stroke centers were comparable to urban stroke centers but exceeded rural nonstroke centers (aOR of 1.66, 1.94, 2.44, 1.5, and 1.72, for antithrombotics within 48 hours of admission, antithrombotics at discharge, anticoagulation for atrial fibrillation/flutter, statin treatment, and smoking cessation, respectively). In-hospital mortality was similar between rural and urban stroke centers (aOR, 1.11 [95% CI, 0.99-1.24]) or nonstroke centers (aOR, 1.00 [95% CI, 0.84-1.18]). CONCLUSIONS: Rural hospitals had lower thrombolysis utilization and slower treatment times than urban hospitals. Rural stroke centers provided comparable secondary stroke prevention treatment to urban stroke centers and exceeded rural nonstroke centers. These results reveal important opportunities and specific targets for rural health equity interventions.
引用
- Man S, Bruckman D, Uchino K, et al. Rural Hospital Performance in Guideline-Recommended Ischemic Stroke Thrombolysis, Secondary Prevention, and Outcomes. Stroke. 2024. PMID: 39234759. doi:10.1161/STROKEAHA.124.047071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。